Home Beverage-specific effects of ethanol consumption on its biological markers
Article
Licensed
Unlicensed Requires Authentication

Beverage-specific effects of ethanol consumption on its biological markers

  • Hidenari Sakuta , Takashi Suzuki , Hiroko Yasuda and Teizo Ito
Published/Copyright: March 10, 2008

Abstract

Background: Serum γ-glutamyltransferase (GGT) and erythrocyte mean corpuscular volume (MCV) are well-known biological markers of excessive ethanol consumption.

Methods: The beverage-specific effects of ethanol consumption on GGT level and MCV value were analyzed cross-sectionally and retrospectively among middle-aged Japanese men who underwent a retirement health checkup (n=974).

Results: Both the consumption of distilled alcohol and that of fermented alcohol positively correlated with the logarithm of GGT [standard regression coefficient (β) 0.261 and 0.174, respectively]. The prevalence rate of elevated GGT levels (≥70 IU/L) was higher among heavy drinkers of distilled alcohol than among heavy drinkers of fermented alcohol (38.8% vs. 27.6%, p=0.013). The MCV value correlated with distilled alcohol consumption (β: 0.212, p<0.0001) but not with fermented alcohol consumption (β: 0.043, not significant). The prevalence rate of an elevated MCV (≥97 fL) was higher among heavy drinkers of distilled alcohol than among heavy drinkers of fermented alcohol (35.3% vs. 16.8%, p<0.001).

Conclusions: These results suggest that MCV is less sensitive for detecting heavy consumption of fermented alcohol than for detecting that of distilled alcohol in apparently healthy middle-aged men.

Clin Chem Lab Med 2008;46:699–702.


Corresponding author: Hidenari Sakuta, Department of Internal Medicine, Self-Defense Forces Central Hospital, 1-2-24 Ikejiri, Setagaya-ku Tokyo 154-8532, Japan

Received: 2007-10-8
Accepted: 2007-12-31
Published Online: 2008-03-10
Published in Print: 2008-05-01

©2008 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Editorial
  2. Comparability of tumor marker immunoassays: still an important issue for clinical diagnostics?
  3. Review
  4. The diagnostic role of autoantibodies in the prediction of organ-specific autoimmune diseases
  5. Validation and Outcome Studies
  6. Alternative antibody for the detection of CA125 antigen: a European multicenter study for the evaluation of the analytical and clinical performance of the Access® OV Monitor assay on the UniCel® DxI 800 Immunoassay System
  7. Alternative antibody for the detection of CA19-9 antigen: a European multicenter study for the evaluation of the analytical and clinical performance of the Access® GI Monitor assay on the UniCel® DxI 800 Immunoassay System
  8. Alternative antibody for the detection of CA15-3 antigen: a European multicenter study for the evaluation of the analytical and clinical performance of the Access® BR Monitor assay on the UniCel® DxI 800 Immunoassay System
  9. Toward metrological traceability in the determination of prostate-specific antigen (PSA): calibrating Beckman Coulter Hybritech Access PSA assays to WHO standards compared with the traditional Hybritech standards
  10. Multicentre evaluation of a new point-of-care test for the determination of CK-MB in whole blood
  11. Down's syndrome screening: population statistic dependency of screening performance
  12. General Clinical Chemistry and Laboratory Medicine
  13. Association between plasma thiols and immune activation marker neopterin in stable coronary heart disease
  14. Role for mitochondrial uncoupling protein-2 (UCP2) in hyperhomocysteinemia and venous thrombosis risk?
  15. Plasma procalcitonin measured by time-resolved amplified cryptate emission (TRACE) in liver transplant patients. A prognosis marker of early infectious and non-infectious postoperative complications
  16. Interactions of lipoprotein(a) with diabetes mellitus, apolipoprotein B and cholesterol enhance the prognostic values for coronary artery disease
  17. Association of thyroid stimulating hormone and coronary lipid risk factors with lipid peroxidation in hypothyroidism
  18. The effect of the mode of delivery on the maternal-neonatal carnitine blood levels and antioxidant status
  19. Time to reconsider the clinical value of immunoglobulin G4 to foods?
  20. Reference Values
  21. Determination of reference intervals for 26 commonly measured biochemical analytes with consideration of long-term within-individual variation
  22. Beverage-specific effects of ethanol consumption on its biological markers
  23. Limits of preservation of samples for urine strip tests and particle counting
  24. Reference ranges and diagnostic thresholds of laboratory markers of cardiac damage and dysfunction in a population of apparently healthy black Africans
  25. Letters to the Editor
  26. External quality assessment schemes for real-time PCR: a statistical procedure to corrective actions
  27. Application of two different microarray-based copy-number detection methodologies – array-comparative genomic hybridization and array-multiplex amplifiable probe hybridization – with identical amplifiable target sequences
  28. Criticism to the article: “Toward standardization of carbohydrate-deficient transferrin (CDT) measurements: I. Analyte definition and proposal of a candidate reference method.” Authors: J.O. Jeppsson et al. Clin Chem Lab Med 2007;45(4):558–562
  29. Standardization of carbohydrate-deficient transferrin: reply to the letter by Tagliaro and Bortolotti
  30. Comment on: Bellini C, Serra G, Risso D, Mazzella M, Bonioli E. Reliability assessment of glucose measurement by HemoCue analyser in a neonatal intensive care unit. Clin Chem Lab Med 2007;45(11):1549–54
  31. Reliability assessment of glucose measurement by HemoCue analyzer in a neonatal intensive care unit: reply to Dr. Joakim Hagvik
Downloaded on 9.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2008.124/pdf
Scroll to top button